Discontinued — last reported Q4 '23

Business Segments · Total Assets

Health & Biosciences — Total Assets

International Flavors & Fragrances Health & Biosciences — Total Assets decreased by 2.4% to $10.67B in Q4 2023 compared to the prior quarter.

Analysis

StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ4 2020
Last reportedQ4 2023Feb 28, 2024
Rolls up toTotal Assets

How to read this metric

Growth in assets relative to revenue may indicate capital expansion, while a decline could signal divestitures or asset depreciation.

Detailed definition

This metric represents the total economic resources controlled by the Health & Biosciences segment, including property,...

Peer comparison

Standard balance sheet metric for segment-level reporting in large industrial or specialty chemical companies.

Metric ID: iff_segment_health_biosciences_assets

Historical Data

3 periods
 Q4 '21Q4 '22Q4 '23
Value$14.77B$10.92B$10.67B
QoQ Change-26.1%-2.4%
YoY Change-26.1%-2.4%
Range$10.67B$14.77B
Avg YoY Growth-14.2%
Median YoY Growth-14.2%
Current Streak2+ quarters decline

Frequently Asked Questions

What is International Flavors & Fragrances's health & biosciences — total assets?
International Flavors & Fragrances (IFF) reported health & biosciences — total assets of $10.67B in Q4 2023.
What does health & biosciences — total assets mean?
The total value of resources and property owned by the segment.